Edmonton-based start-up to develop personalized cancer therapy models: EDMONTON (March 29, 2018)–48Hour Discovery Inc. (48HD) announced today that they have signed an agreement with Precision Therapeutics Inc. (NASDAQ:AIPT) and its wholly owned subsidiary, TumorGenesis Inc. 48HD will grant access...

Edmonton – 48Hour Discovery INC. and the Alberta Innovates have signed an Industry Commercialization Associates Investment Agreement to cement funding for 48Hour Discovery’s business management and marketing development.  The two corporations agreed today in terms for undisclosed investment to...

Edmonton – 48Hour Discovery INC. announced today that it has signed an Industry r&D Associates Investment Agreement with Alberta Innovates. The investment directly supports 48Hour Discovery for a two-year project, focusing on commercializing products and services in molecular discovery....

“We are extremely pleased to see a core service being commercialized… Supporting 48Hour Discovery fits with our strategic goals of spurring job creation and fostering start-up success in Canada.” said Dr. Todd Lowary, GlycoNet Scientific Director. To see full...

Radio Interview from Wednesday August 16 2017

Our company was recently highlighted in the Edmonton Journal: Edmonton startup wants to put Alberta at epicentre of molecular discoveries To read the full article, click here.

We are excited to celebrate the official launch of 48Hour Discovery Inc. on August 15th 2017 kindly made possible by the Alberta Glycomics Centre!